Arno Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	2006 - 2010
Period Ending	Dec '25 Dec 11, 2025	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	2006 - 2010
Market Capitalization	0	7	14	57	18	54	Upgrade
Market Cap Growth	-92.86%	-48.28%	-76.13%	213.70%	-66.57%	422.40%	Upgrade
Enterprise Value	-	7	2	61	19	50	Upgrade
Last Close Price	0.00	0.34	0.67	2.80	4.00	12.00	Upgrade
PE Ratio	-	-	1.75	-	-	-	Upgrade
PB Ratio	0.00	-0.82	4.60	-4.55	-1.60	10.75	Upgrade
P/TBV Ratio	-	-	-	-	-	40.12	Upgrade
Debt / Equity Ratio	0.00	-0.24	0.00	-	-0.04	-	Upgrade
Quick Ratio	1.39	0.02	3.69	6.86	3.37	3.40	Upgrade
Current Ratio	1.52	0.08	3.80	6.89	3.43	3.55	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-93.50%	Upgrade
Return on Assets (ROA)	-500.04%	-194.74%	-75.05%	-53.24%	-68.01%	-45.79%	Upgrade
Return on Capital Employed (ROCE)	-1335.80%	346.60%	-346.30%	-73.70%	-112.30%	-151.10%	Upgrade
Earnings Yield	-138758.26%	-163.44%	57.08%	-69.53%	-79.13%	-14.54%	Upgrade
FCF Yield	-	-141.54%	-138.29%	-24.97%	-51.81%	-12.61%	Upgrade
Buyback Yield / Dilution	-78.21%	17.74%	-230.09%	-65.54%	-5.24%	-69.09%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.